PT  - JOURNAL ARTICLE
AU  - Mossad, Sherif B.
TI  - Demystifying FluMist, a new intranasal, live influenza vaccine
DP  - 2003 Sep 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 801--806
VI  - 70
IP  - 9
4099  - http://www.ccjm.org/content/70/9/801.short
4100  - http://www.ccjm.org/content/70/9/801.full
SO  - Cleve Clin J Med2003 Sep 01; 70
AB  - FluMist—a cold-adapted, live-attenuated, trivalent, intranasal influenza virus vaccine approved by the US Food and Drug Administration on June 17, 2003—has been shown to be safe and effective, but its role in the general prevention of influenza is yet to be defined. Intranasal administration is expected to be more acceptable than parenteral, particularly in children, but the potential for the shedding of live virus may pose a risk to anyone with a compromised immune system.